IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 27 filers reported holding IMMUCELL CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,654 | +17.8% | 53,213 | +16.4% | 0.00% | – |
| Q2 2023 | $233,207 | +18.9% | 45,727 | +20.1% | 0.00% | – |
| Q1 2023 | $196,122 | +84072.5% | 38,082 | 0.0% | 0.00% | – |
| Q4 2022 | $233 | -99.9% | 38,082 | -0.1% | 0.00% | – |
| Q3 2022 | $285,000 | +39.7% | 38,135 | +61.8% | 0.00% | – |
| Q2 2022 | $204,000 | -6.4% | 23,573 | +4.0% | 0.00% | – |
| Q1 2022 | $218,000 | +21.8% | 22,672 | +1.0% | 0.00% | – |
| Q4 2021 | $179,000 | -13.5% | 22,442 | 0.0% | 0.00% | – |
| Q3 2021 | $207,000 | +6.7% | 22,442 | +9.8% | 0.00% | – |
| Q2 2021 | $194,000 | -1.0% | 20,434 | 0.0% | 0.00% | – |
| Q1 2021 | $196,000 | +62.0% | 20,434 | 0.0% | 0.00% | – |
| Q4 2020 | $121,000 | +10.0% | 20,434 | 0.0% | 0.00% | – |
| Q3 2020 | $110,000 | +14.6% | 20,434 | 0.0% | 0.00% | – |
| Q2 2020 | $96,000 | +24.7% | 20,434 | 0.0% | 0.00% | – |
| Q1 2020 | $77,000 | – | 20,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERRITT CAPITAL MANAGEMENT INC | 154,300 | $1,285,000 | 0.38% |
| HEARTLAND ADVISORS INC | 199,600 | $1,663,000 | 0.11% |
| Minerva Advisors LLC | 14,559 | $121,000 | 0.06% |
| Essex Financial Services, Inc. | 23,776 | $198,000 | 0.04% |
| SHUFRO ROSE & CO LLC | 50,791 | $423,000 | 0.04% |
| INGALLS & SNYDER LLC | 91,511 | $762,000 | 0.03% |
| RBF Capital, LLC | 13,086 | $109,000 | 0.01% |
| FLAGSHIP HARBOR ADVISORS, LLC | 3,000 | $26,000 | 0.01% |
| Renaissance Technologies | 96,100 | $801,000 | 0.00% |
| MORGAN STANLEY | 11,732 | $98,000 | 0.00% |